W. Brooks Gentry
Gründer bei InterveXion Therapeutics LLC
Profil
W.
Brooks Gentry is the founder and Chief Medical Officer of InterveXion Therapeutics LLC, which is founded in 2004.
He is currently a Professor at The University of Arkansas, a position he has held since 2000.
Aktive Positionen von W. Brooks Gentry
| Unternehmen | Position | Beginn |
|---|---|---|
InterveXion Therapeutics LLC
 InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Gründer | 17.09.2009 |
| The University of Arkansas | Corporate Officer/Principal | 17.09.2009 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
